Resources

CADTH Emerging Health Technology for COVID-19: Sarilumab

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: September 2, 2020

Also available in Français

What You Should Know About Dexamethasone for Treating COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: August 20, 2020

Also available in Français

Lopinavir-Ritonavir for the Treatment and Prevention of COVID-19: A Review of Clinical Effectiveness

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: August 19, 2020

Also available in Français

CADTH Emerging Health Technology for COVID-19: Favipiravir

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: August 17, 2020

Also available in Français

Dexamethasone in Patients Hospitalized for COVID-19

Product: — Science Table

Drug Interventions Treatments

covid19-sciencetable.ca Last Updated: August 12, 2020

Dexamethasone in the Treatment of Hospitalized Patients With COVID-19: A Critical Appraisal of the RECOVERY Study

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: July 24, 2020

Also available in Français

Gabapentin, Phenobarbital, Diazepam, and Lorazepam for the Treatment of Alcohol Withdrawal: Clinical Effectiveness and Guidelines

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: June 23, 2020

Also available in Français

Methoxyflurane for Acute Pain: Clinical Effectiveness

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: May 25, 2020

Also available in Français